As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention ...

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir, also CAB-LA, for HIV treatment in 133 countries, per The Hindu report. This follows ViiV ...

Lenacapavir (LEN) has arrived in South Africa, and this injectable form of pre-exposure prophylaxis (PrEP) marks a major ...

Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay. New research suggests that injectable, ...

Long-acting injectable antiretroviral therapy improves treatment outcomes in individuals with HIV type 1 (HIV 1) who face adherence challenges, thereby addressing a persistent barrier in routine ...

The Food and Drug Administration (FDA) approved an injectable medication to be used as an HIV prevention drug on Wednesday. People would only need to use the drug every six months, or twice a year, ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and ...

Long-acting CAB+RPV is preferred by patients for ART due to reduced dosing frequency and stigma, with 89% switching after viral suppression. Studies like PILLAR and EBONI confirm the effectiveness and ...

Subscribe to our newsletter and stay updated on the latest developments and special offers!